Growth Metrics

Myomo (MYO) Current Leases (2020 - 2025)

Myomo posted quarterly Current Leases of $494662.0 for Q4 2025, down 33.87% year-on-year from $748021.0 in Q4 2024, and up 6.55% on a QoQ basis from $464239.0 in Q3 2025.

Myomo (MYO) has 6 years of Current Leases data on file, last reported at $494662.0 in Q4 2025.

  • For the quarter ending Q4 2025, Current Leases fell 33.87% year-over-year to $494662.0; the trailing twelve-month figure through Dec 2025 stood at $494662.0 (down 33.87% YoY), and the FY2025 full-year result was $494662.0, down 33.87% from the prior year.
  • Current Leases for Q4 2025 stood at $494662.0, up from $464239.0 in the prior quarter.
  • Across five years, Current Leases topped out at $765616.0 in Q1 2025 and bottomed at $181783.0 in Q2 2023.
  • The 5-year median for Current Leases is $416005.5 (2022), against an average of $403855.2.
  • The widest annual swing landed in 2021, when Current Leases jumped 1722.84%; it then plunged 58.37% in 2023.
  • A 5-year view of Current Leases shows it stood at $333380.0 in 2021, then rose by 6.1% to $353701.0 in 2022, then jumped by 37.44% to $486143.0 in 2023, then soared by 53.87% to $748021.0 in 2024, then tumbled by 33.87% to $494662.0 in 2025.
  • The last three Current Leases figures came in at $494662.0 (Q4 2025), $464239.0 (Q3 2025), and $460351.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 24.30 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 20.50 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 35.80 Mn
10 Myomo 44.63 Mn 26.23 Mn - 494,662.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 494,662.00
Sep 30, 2025 464,239.00
Jun 30, 2025 460,351.00
Mar 31, 2025 765,616.00
Dec 31, 2024 748,021.00
Sep 30, 2024 205,464.00
Jun 30, 2024 316,600.00
Mar 31, 2024 421,514.00
Dec 31, 2023 486,143.00
Sep 30, 2023 456,064.00
Jun 30, 2023 181,783.00
Mar 31, 2023 275,028.00
Dec 31, 2022 353,701.00
Sep 30, 2022 441,386.00
Jun 30, 2022 436,694.00
Mar 31, 2022 410,497.00
Dec 31, 2021 333,380.00
Sep 30, 2021 301,878.00
Jun 30, 2021 319,624.00
Mar 31, 2021 204,460.00
Dec 31, 2020 18,289.00